Public Meeting Notice

Guidelines for the Use of Buprenorphine

Second Buprenorphine Treatment Guidelines Committee Meeting

Description: Committee members will meet to discuss and possible adopt the draft guidelines drafted by the Buprenorphine Treatment Guidelines Workgroup

Thursday, October 19, 2017, 8:30 a.m. -11:30 a.m. CST

Ground Floor Hearing Room
Andrew Jackson Building
500 Deaderick Street, Nashville, TN 37243

*A state-issued I.D. is required for entry. Enter the building on the 5th Avenue North side of the Andrew Jackson Building.

How Can I Participate Without Attending In Person?:
Call Conference Line (615) 741-7735 and/or use the Adobe Connect web conference located at:

*All Committee meetings are open to the general public; however, seating will be extremely limited and will be offered to the Committee and its staff first.  Additionally, please be aware that discussion amongst the Committee and its staff will be given priority during Committee meetings so that the Committee can do their work. If you would like to participate, it is recommended that you do so using the Conference Line # and/or Adobe Connect web conference link provided above.

Contact: Kurt Hippel, Office of Legislation, Rules & Privacy